The below specifications apply to the mAMP: Methamphetamine panels of the One Step Drug Tests. This includes the 1-panel One Step Methamphetamine Drug Test - plus any multi-panel drug test containing an mAMP panel.
The following table lists compounds that are positively detected in urine by the mAMP One Step Methamphetamine Test Strip at 5 minutes. d-Methamphetamine is the target compound.
A side-by-side comparison was conducted using the mAMP One Step Methamphetamine Test Strip and a leading commercially available mAMP rapid test. Testing was performed on 300 clinical specimens. Ten percent of the specimens employed were either at -25% or +25% level of the cutoff concentration of 1,000 ng/ml Methamphetamine. Presumptive positive results were confirmed by GC/MS. The following results were tabulated:
|Method||Other mAMP Rapid Test||Total Results|
|mAMP One Step Test Strip||Results||Positive||Negative|
|% Agreement With Commercial Kit||98%||>99%||99%|
When compared to the GC/MS lab testing method at the cutoff concentration of 1,000 ng/ml, the following results were tabulated:
|mAMP One Step Test Strip||Results||Positive||Negative|
|% Agreement With GC/MS Analysis||99%||94%||96%|
Eighty (80) of these samples were also run using the mAMP One Step Methamphetamine Test Strip by an untrained operator at a different site. Based on GC/MS data, the operator obtained a statistically similar Positive Agreement, Negative Agreement and Overall Agreement rate as the laboratory personnel.
A drug-free urine pool was spiked with Methamphetamine at the following concentrations: 0 ng/ml, 500 ng/ml, 750 ng/ml, 1,000 ng/ml, 1,250 ng/ml and 1,500 ng/ml. The result demonstrates >99% accuracy at 50% above and 50% below the cutoff concentration. The data are summarized below:
|Methamphetamine Concentration (ng/ml)||Percent of Cutoff||n||Visual Result|
A study was conducted at 3 physician's offices by untrained operators using 3 different lots of product to demonstrate the within run, between run and between operator precision. An identical panel of coded specimens containing no Methamphetamine, 25% Methamphetamine above and below the cutoff and 50% Methamphetamine above and below the 1,000 ng/ml cutoff was provided to each site. The results are given below:
|Methamphetamine Concentration (ng/ml)||n||Site A||Site B||Site C|
A study was conducted to determine the cross-reactivity of the test with compounds in either drug-free urine or Methamphetamine positive urine. The following compounds show no cross-reactivity (were not detected positive) when tested with the mAMP One Step Methamphetamine Test Strip at a concentration of 100,000 ng/ml.
|Non Cross-Reacting Compounds|
|4-Acetamidophenol; Acetophenetidin; N-Acetylprocainamide; Acetylsalicylic acid; Aminopyrine; Amitryptyline; Amobarbital; Amoxicillin; d-Amphetamine; dl-Amphetamine; l-Amphetamine; Ampicillin; Apomorphine; Ascorbic acid; Aspartame; Atropine; Benzilic acid; Benzoic acid; Benzoylecgonine; Benzphetamine; Bilirubin; Brompheniramine; Caffeine; Cannabidiol; Chloral hydrate; Chloramphenicol; Chlordiazepoxide; Chlorothiazide; dl-Chlorpheniramine; Chlorpromazine; Chloroquine; Cholesterol; Clomipramine; Clonidine; Cocaethylene; Cocaine; Codeine; Cortisone; l-Cotinine; Creatinine; Deoxycorticosterone; Dextromethorphan; Diazepam; Diclofenac; Diflunisal; Digoxin; Diphenhydramine; Doxylamine; Ecgonine hydrochloride; Ecgonine methyl ester; (1R,2S)-l-Ephedrine; l-Epinephrine; l-pseudo-Ephedrine; Erythromycin; B-Estradiol; Estrone 3-sulfate; Ethyl p-aminobenzoate; Fenfluramine; Fenoprofen; Furosemide; Gentisic acid; Hemoglobin; Hydralazine; Hydrochlorothiazide; Hydrocodone; Hydrocortisone; p-Hydroxyamphetamine; o-Hydroxyhippuric acid; 3-Hydroxytyramine; Ibuprofen; Imipramine; Iproniazid; l-Isoproterenol; Isoxsuprine; Ketamine; Ketoprofen; Labetalol; Levorphanol; Loperamide; Maprotiline; Meperedine; Meprobamate; Methadone; Methoxyphenamine; d-3,4-Methylenedioxyamphetamine; 3,4-Methylenedioxyethylamphetamine; Methylphenidate; Morphine 3-B-D-glucuronide; Nalidixic acid; Naloxone; Naltrexone; Naproxen; Niacinamide; Nifedipine; Norethindrone; d-Norpropoxyphene; Noscapine; dl-Octopamine; Oxalic acid; Oxazepam; Oxolinic acid; Oxycodone; Oxymetazoline; Papaverine; Penicillin-G; Pentobarbital; Perphenazine; Phencyclidine; Phenelzine; Phenobarbital; Phentermine; l-Phenylephrine; B-Phenylethylamine; Phenylpropanolamine; Prednisolone; Prednisone; Procaine; Promazine; Promethazine; dl-Propranolol; d-Propoxyphene; d-Pseudoephedrine; Quinacrine; Quinidine; Quinine; Ranitidine; Salicylic acid; Secobarbital; Serotonin (5-Hydroxytryptamine); Sulfamethazine; Sulindac; Temazepam; Tetracycline; Tetrahydrocortisone 3-acetate; Tetrahydrocortisone 3-(B-D-glucuronide); Tetrahydrozoline; Thiamine; Thioridazine; Tolbutamide; trans-2-Phenylcyclopropylamine; Triamterene; Trifluoperazine; Trimethoprim; Trimipramine; Tryptamine; dl-Tryptophan; Tyramine; dl-Tyrosine; Uric acid; Verapamil; Zomepirac|
Fifteen (15) urine samples of normal, high, and low specific gravity ranges were spiked with 500 ng/ml and 1,500 ng/ml of Methamphetamine respectively. The mAMP One Step Methamphetamine Test Strip was tested in duplicate using the fifteen neat and spiked urine samples. The results demonstrate that varying ranges of urinary specific gravity does not affect the test results.
The pH of an aliquoted negative urine pool was adjusted to a pH range of 5 to 9 in 1 pH unit increments and spiked with Methamphetamine to 500 ng/ml and 1,500 ng/ml. The spiked, pH-adjusted urine was tested with the mAMP One Step Methamphetamine Test Strip in duplicate. The results demonstrate that varying ranges of pH does not interfere with the performance of the test.